Back to GLENMEDE TRUST CO NA GLENMEDE TRUST CO NA

ABTABT
Showing 6 of 30 quarters

Position history for GLENMEDE TRUST CO NAGLENMEDE TRUST CO NA's holdings in ABBOTT LABORATORIES

GLENMEDE TRUST CO NA holds 1M shares of ABT (ABBOTT LABORATORIES), worth $94M as of 2026-Q2. The position was decreased (-3.2% shares). ABT represents 0.4% of GLENMEDE TRUST CO NA's portfolio.

Current Value

$94M

Current Shares

1M

Total Value Change

-$78.9M

Total Shares Change

-481,056

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1M
-3.2%
$94M0.4%$90.10
0
2026-Q1
Decreased
1.1M
-5.7%
$109.8M0.5%$101.31
0
2025-Q4
Decreased
1.1M
-13.3%
$142.2M0.7%$123.00
0
2025-Q1
Decreased
1.3M
-4.1%
$173.7M0.9%$128.48
0
2024-Q4
Decreased
1.4M
-10.0%
$154.4M0.8%$108.98
0
2024-Q3
Decreased
1.5M
-1.3%
$172.9M0.8%$109.33
0

Other major holders of ABT: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used